AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33947344 — intervention group
Group type: COMPARATOR
Intervention: Reference treatment without ivermectin
Number of subjects: 66
Study 34521568 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D levels (intervention not specified in terms of dosage or duration)
Number of subjects: 0
Study 34521568 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D levels (using MR‐Egger regression)
Number of subjects: 0
Study 34521568 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D levels (using WM1 method)
Number of subjects: 0
Study 34521568 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D levels (using WM2 method)
Number of subjects: 0
Study 32045565 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D ultrasonography plus 3D-printed models
Number of subjects: 96
Study 32045565 — intervention group
Group type: COMPARATOR
Intervention: Ultrasonography only
Number of subjects: 96
Study 35295056 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthodontic treatment with premolar extraction
Number of subjects: 98
Study 35295056 — intervention group
Group type: COMPARATOR
Intervention: Orthodontic treatment without premolar extraction
Number of subjects: 98
Study 32128561 — intervention group
Group type: EXPERIMENTAL
Intervention: Home pregnancy tests (HPTs) plus standard protocol (n=720)
Number of subjects: 1493
Study 32128561 — intervention group
Group type: COMPARATOR
Intervention: Standard protocol alone (n=773)
Number of subjects: 1493
Study 32985950 — intervention group
Group type: EXPERIMENTAL
Intervention: TTM24 (target temperature management for 24 hours)
Number of subjects: 117
Study 32985950 — intervention group
Group type: COMPARATOR
Intervention: TTM48 (target temperature management for 48 hours)
Number of subjects: 117
Study 32985950 — intervention group
Group type: EXPERIMENTAL
Intervention: TTM24
Number of subjects: 117
Study 32985950 — intervention group
Group type: COMPARATOR
Intervention: TTM48
Number of subjects: 117
Study 32147069 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) meditation/mindfulness sessions
Number of subjects: 52
Study 32147069 — intervention group
Group type: COMPARATOR
Intervention: Standard care (non-VR)
Number of subjects: 52
Study 35578182 — intervention group
Group type: EXPERIMENTAL
Intervention: Fremanezumab treatment
Number of subjects: 1003
Study 34368938 — intervention group
Group type: EXPERIMENTAL
Intervention: XVd (selinexor, bortezomib, dexamethasone)
Number of subjects: 0
Study 35143273 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized probabilistic risk visual aid
Number of subjects: 1301
Study 35143273 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual aid and a video narrative
Number of subjects: 1301
Study 35143273 — intervention group
Group type: COMPARATOR
Intervention: General risk information
Number of subjects: 1301
Study 33314230 — intervention group
Group type: EXPERIMENTAL
Intervention: Normalized Randomized Survival Probabilities (NRSP) residuals
Number of subjects: 0
Study 33314230 — intervention group
Group type: COMPARATOR
Intervention: Traditional goodness-of-fit (GOF) test method
Number of subjects: 0
Study 33314230 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonlinear test based on NRSP residuals
Number of subjects: 0
Study 33314230 — intervention group
Group type: COMPARATOR
Intervention: Graphical diagnostics with CS residuals
Number of subjects: 0
Study 35683437 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture treatment (AT) 3 times a week for 8 weeks.
Number of subjects: 100
Study 35683437 — intervention group
Group type: COMPARATOR
Intervention: Control group without acupuncture.
Number of subjects: 100
Study 35569036 — intervention group
Group type: EXPERIMENTAL
Intervention: BI 1015550 (18 mg twice daily)
Number of subjects: 147
Study 35569036 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 147
Study 33079921 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical moxifloxacin 0.5% plus CXL
Number of subjects: 0
Study 33079921 — intervention group
Group type: COMPARATOR
Intervention: Topical moxifloxacin 0.5%
Number of subjects: 0
Study 32927476 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 minutes of hypoglycemia (p-glucose < 2.9 mmol/L) followed by a euglycemic clamp
Number of subjects: 18
Study 32927476 — intervention group
Group type: COMPARATOR
Intervention: Euglycemic clamp without antecedent hypoglycemia
Number of subjects: 18
Study 32927476 — intervention group
Group type: EXPERIMENTAL
Intervention: Antecedent hypoglycemic episodes lasting 30 minutes
Number of subjects: 18
Study 33497862 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 2267
Study 33497862 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2267
Study 34129728 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine/tetracaine 7%/7% peel cream (L/T‐pC) applied 45 minutes before laser treatment
Number of subjects: 30
Study 34129728 — intervention group
Group type: COMPARATOR
Intervention: Control (emollient cream)
Number of subjects: 30
Study 33406977 — intervention group
Group type: EXPERIMENTAL
Intervention: Thyroid peroxidase antibodies (TPOAb)
Number of subjects: 2507
Study 33406977 — intervention group
Group type: EXPERIMENTAL
Intervention: Thyroglobulin antibodies (TgAb)
Number of subjects: 2507
Study 33406977 — intervention group
Group type: EXPERIMENTAL
Intervention: Subclinical hypothyroidism (SCH)
Number of subjects: 2507
Study 33406977 — intervention group
Group type: EXPERIMENTAL
Intervention: Goitre prevalence
Number of subjects: 2507
Study 33406977 — intervention group
Group type: EXPERIMENTAL
Intervention: Urine iodine concentration (UIC)
Number of subjects: 2507
Study 33406977 — intervention group
Group type: EXPERIMENTAL
Intervention: Thyroglobulin levels
Number of subjects: 2507
Study 36332654 — intervention group
Group type: EXPERIMENTAL
Intervention: Full PopART intervention (arm A) and intervention with ART according to national guidelines (arm B)
Number of subjects: 0
Study 36332654 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (arm C)
Number of subjects: 0
Study 33618195 — intervention group
Group type: EXPERIMENTAL
Intervention: Informed Choice (self-matching)
Number of subjects: 402
Study 33618195 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 402
Study 35550716 — intervention group
Group type: EXPERIMENTAL
Intervention: Incisional negative pressure wound therapy dressing
Number of subjects: 80
Study 35550716 — intervention group
Group type: COMPARATOR
Intervention: Standard dressing
Number of subjects: 80
Study 35550716 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 80
Study 33849517 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive internet-based intervention
Number of subjects: 250
Study 33849517 — intervention group
Group type: COMPARATOR
Intervention: Web-based intervention without sexual health information and interactive components (Control)
Number of subjects: 250
Study 34845722 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy relationships program delivered by facilitators not employed by the high schools
Number of subjects: 1135
Study 34845722 — intervention group
Group type: COMPARATOR
Intervention: Curricula-as-usual
Number of subjects: 1135
Study 32226076 — intervention group
Group type: EXPERIMENTAL
Intervention: High guidance prompts
Number of subjects: 32
Study 32226076 — intervention group
Group type: COMPARATOR
Intervention: Low guidance prompts
Number of subjects: 32
Study 32226076 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile learning module
Number of subjects: 32
Study 36198293 — intervention group
Group type: EXPERIMENTAL
Intervention: Late eating
Number of subjects: 0
Study 32912627 — intervention group
Group type: EXPERIMENTAL
Intervention: TENS
Number of subjects: 40
Study 32912627 — intervention group
Group type: EXPERIMENTAL
Intervention: tDCS
Number of subjects: 40
Study 32912627 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 40
Study 36335570 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated microfinance/livelihood and community‐based rehabilitation (IMCBR) programme
Number of subjects: 251
Study 36335570 — intervention group
Group type: COMPARATOR
Intervention: Community-based rehabilitation (CBR)
Number of subjects: 251
Study 36335570 — intervention group
Group type: COMPARATOR
Intervention: Care-as-usual
Number of subjects: 251
Study 33559444 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural nerve block with 20 mL 0.375% ropivacaine 30 min before anesthesia induction
Number of subjects: 60
Study 33559444 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) at bilateral Neima point and Neiguan (PC 6) for 30 min before anesthesia induction
Number of subjects: 60
Study 33559444 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia alone (Control group)
Number of subjects: 60
Study 32479749 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-to-severe MR
Number of subjects: 1443
Study 32479749 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-to-severe AS
Number of subjects: 1443
Study 32479749 — intervention group
Group type: EXPERIMENTAL
Intervention: Both moderate-to-severe MR and AS
Number of subjects: 1443
Study 32479749 — intervention group
Group type: COMPARATOR
Intervention: No VHD
Number of subjects: 1443
Study 33548080 — intervention group
Group type: EXPERIMENTAL
Intervention: LA-enriched diet (sunflower oil, 30-50 mL, 62-63% LA)
Number of subjects: 130
Study 33548080 — intervention group
Group type: EXPERIMENTAL
Intervention: ALA-enriched diet (Camelina sativa oil, 30-50 mL, 30-35% ALA)
Number of subjects: 130
Study 33036371 — intervention group
Group type: EXPERIMENTAL
Intervention: ToyBox intervention
Number of subjects: 4970
Study 33036371 — intervention group
Group type: EXPERIMENTAL
Intervention: Process evaluation scores from teachers and parents/caregivers
Number of subjects: 4970
Study 32124625 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxybutynin 5 mg tablet twice a day for 3 months
Number of subjects: 60
Study 32124625 — intervention group
Group type: COMPARATOR
Intervention: Transcutaneous Tibial Nerve Stimulation (TTNS) daily for 3 months
Number of subjects: 60
Study 33141450 — intervention group
Group type: EXPERIMENTAL
Intervention: Unmasked attentional blink with visual T2s
Number of subjects: 0
Study 33141450 — intervention group
Group type: EXPERIMENTAL
Intervention: Unmasked attentional blink with auditory T2s
Number of subjects: 0
Study 32347958 — intervention group
Group type: EXPERIMENTAL
Intervention: Holy Name Meditation Program
Number of subjects: 45
Study 34865304 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (PCOS-M)
Number of subjects: 88
Study 34865304 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PCOS-P)
Number of subjects: 88
Study 34865304 — intervention group
Group type: COMPARATOR
Intervention: Healthy Controls (HC)
Number of subjects: 88
Study 33210328 — intervention group
Group type: EXPERIMENTAL
Intervention: Bathing between 24-48 hours after birth
Number of subjects: 80
Study 33210328 — intervention group
Group type: COMPARATOR
Intervention: Bathing between 48-72 hours after birth
Number of subjects: 80
Study 36175648 — intervention group
Group type: EXPERIMENTAL
Intervention: PragmaVAC
Number of subjects: 59
Study 36175648 — intervention group
Group type: COMPARATOR
Intervention: Gauze (Control)
Number of subjects: 59
Study 34455507 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E (α-tocopherol)
Number of subjects: 131
Study 34455507 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium
Number of subjects: 131
Study 34455507 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc
Number of subjects: 131
Study 34455507 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 131
Study 32347766 — intervention group
Group type: EXPERIMENTAL
Intervention: LPG stove and an 18-month supply of free LPG with behavioral reinforcements
Number of subjects: 3200
Study 32347766 — intervention group
Group type: COMPARATOR
Intervention: Control arm (no LPG stove and fuel distribution)
Number of subjects: 3200
Study 33411326 — intervention group
Group type: EXPERIMENTAL
Intervention: Instagram posts from the IVF community
Number of subjects: 452
Study 34264484 — intervention group
Group type: EXPERIMENTAL
Intervention: Eating disorders (EDs)
Number of subjects: 34
Study 34264484 — intervention group
Group type: EXPERIMENTAL
Intervention: High-functioning autism spectrum disorders (HF‐ASDs)
Number of subjects: 34
Study 34264484 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls (HC)
Number of subjects: 34
Study 34264484 — intervention group
Group type: EXPERIMENTAL
Intervention: Eating disorders (EDs) and high-functioning autism spectrum disorders (HF‐ASDs)
Number of subjects: 34
Study 33536385 — intervention group
Group type: EXPERIMENTAL
Intervention: Vonoprazan-based second-line therapy
Number of subjects: 33
Study 32976204 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 42
Study 32976204 — intervention group
Group type: COMPARATOR
Intervention: Moderate Intensity Continuous Training (MICT)
Number of subjects: 42
Study 34629186 — intervention group
Group type: EXPERIMENTAL
Intervention: Biosynthetic cellulose dressing (Epiprotect® S2Medical AB)
Number of subjects: 24
Study 34629186 — intervention group
Group type: COMPARATOR
Intervention: Porcine xenograft (EZ Derm®, Mölnlycke Health Care)
Number of subjects: 24
Study 33650089 — intervention group
Group type: EXPERIMENTAL
Intervention: TEAS combined with dexamethasone and tropisetron
Number of subjects: 62
Study 33650089 — intervention group
Group type: COMPARATOR
Intervention: Control group (dexamethasone and tropisetron)
Number of subjects: 62
Study 33127971 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) treatment in PCOS patients (PCOS-T)
Number of subjects: 109
Study 33127971 — intervention group
Group type: COMPARATOR
Intervention: Control group (PCOS-C)
Number of subjects: 109
Study 616850902 — intervention group
Group type: EXPERIMENTAL
Intervention: Breakfast Skipping Day (BSD)
Number of subjects: 17
Study 616850902 — intervention group
Group type: EXPERIMENTAL
Intervention: Dinner Skipping Day (DSD)
Number of subjects: 17
Study 616850902 — intervention group
Group type: COMPARATOR
Intervention: 3-meal control
Number of subjects: 17
Study 35681255 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional supplementation initiated prior to conception (arm 1)
Number of subjects: 2337
Study 35681255 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional supplementation initiated in early pregnancy (arm 2)
Number of subjects: 2337
Study 35681255 — intervention group
Group type: COMPARATOR
Intervention: Control arm (arm 3)
Number of subjects: 2337
Study 34222163 — intervention group
Group type: EXPERIMENTAL
Intervention: Expressive writing intervention
Number of subjects: 0
Study 34222163 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 36254858 — intervention group
Group type: EXPERIMENTAL
Intervention: Family care following early deprivation
Number of subjects: 143
Study 36254858 — intervention group
Group type: COMPARATOR
Intervention: Care-as-usual
Number of subjects: 143
Study 34211004 — intervention group
Group type: EXPERIMENTAL
Intervention: Original communication calls
Number of subjects: 0
Study 34211004 — intervention group
Group type: COMPARATOR
Intervention: Increased spectro-temporal distortion in communication calls
Number of subjects: 0
Study 35525262 — intervention group
Group type: EXPERIMENTAL
Intervention: Early invasive strategy group (primary percutaneous coronary intervention, PPCI)
Number of subjects: 366
Study 35525262 — intervention group
Group type: COMPARATOR
Intervention: Conservative strategy group (optimal medical therapy with primary PCI not performed)
Number of subjects: 366
Study 34319944 — intervention group
Group type: EXPERIMENTAL
Intervention: II + ID resistance training (RT)
Number of subjects: 320
Study 34319944 — intervention group
Group type: EXPERIMENTAL
Intervention: DD resistance training (RT)
Number of subjects: 320
Study 34319944 — intervention group
Group type: COMPARATOR
Intervention: II + ID control (CTL)
Number of subjects: 320
Study 34319944 — intervention group
Group type: COMPARATOR
Intervention: DD control (CTL)
Number of subjects: 320
Study 34000907 — intervention group
Group type: EXPERIMENTAL
Intervention: Crisis/Broken stories
Number of subjects: 4497
Study 34000907 — intervention group
Group type: EXPERIMENTAL
Intervention: Counterfeit stories
Number of subjects: 4497
Study 34000907 — intervention group
Group type: EXPERIMENTAL
Intervention: Problem explored stories
Number of subjects: 4497
Study 34000907 — intervention group
Group type: EXPERIMENTAL
Intervention: Problem-focused stories
Number of subjects: 4497
Study 34000907 — intervention group
Group type: COMPARATOR
Intervention: All stories
Number of subjects: 4497
Study 35067819 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized management program comprising a tailored chronic disease management plan and education
Number of subjects: 563
Study 35067819 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 563
Study 33806089 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical deep muscle flexion exercises for 4 weeks
Number of subjects: 32
Study 33806089 — intervention group
Group type: COMPARATOR
Intervention: Stretching exercises for 4 weeks
Number of subjects: 32
Study 33141187 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal blood lead levels (BLLs)
Number of subjects: 20000
Study 35734811 — intervention group
Group type: EXPERIMENTAL
Intervention: Telenursing intervention (telephone calls twice a week for the first six weeks, then once a week until week 12)
Number of subjects: 95
Study 35734811 — intervention group
Group type: EXPERIMENTAL
Intervention: Telenursing intervention
Number of subjects: 95
Study 35734811 — intervention group
Group type: COMPARATOR
Intervention: Control group (no telenursing intervention)
Number of subjects: 95
Study 32506124 — intervention group
Group type: EXPERIMENTAL
Intervention: Cohesive polydensified matrix hyaluronic acid filler (CPM-HA)
Number of subjects: 48
Study 32506124 — intervention group
Group type: EXPERIMENTAL
Intervention: Small-particle hyaluronic acid filler with 0.3% lidocaine (SP-HAL)
Number of subjects: 48
Study 32699167 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote monitoring strategy using wearable biosensors
Number of subjects: 200
Study 32699167 — intervention group
Group type: COMPARATOR
Intervention: Standard strategy (control group)
Number of subjects: 200
Study 32568788 — intervention group
Group type: EXPERIMENTAL
Intervention: Chest ultrasound
Number of subjects: 89
Study 32568788 — intervention group
Group type: COMPARATOR
Intervention: Routine diagnostic approach
Number of subjects: 89
Study 34280944 — intervention group
Group type: EXPERIMENTAL
Intervention: Room temperature contrast material (23°C)
Number of subjects: 218
Study 34280944 — intervention group
Group type: COMPARATOR
Intervention: Prewarmed contrast material (37°C)
Number of subjects: 218
Study 33625387 — intervention group
Group type: EXPERIMENTAL
Intervention: Anatomical teeth (AT)
Number of subjects: 50
Study 33625387 — intervention group
Group type: COMPARATOR
Intervention: Nonanatomical teeth (NT)
Number of subjects: 50
Study 32427553 — intervention group
Group type: EXPERIMENTAL
Intervention: 635 nm diode laser (8‐mm diameter handpiece in contact mode, delivering 8 J/cm2 over a period of 20 sec applied over sensitive points)
Number of subjects: 42
Study 32427553 — intervention group
Group type: COMPARATOR
Intervention: Placebo (same protocol without laser activation)
Number of subjects: 42
Study 32427553 — intervention group
Group type: EXPERIMENTAL
Intervention: 635 nm diode laser
Number of subjects: 42
Study 35994200 — intervention group
Group type: EXPERIMENTAL
Intervention: Ozanimod (Zeposia®)
Number of subjects: 0
Study 35994200 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33595879 — intervention group
Group type: EXPERIMENTAL
Intervention: Early on-demand (EOD) drainage
Number of subjects: 30
Study 33595879 — intervention group
Group type: COMPARATOR
Intervention: Standard management (SM)
Number of subjects: 30
Study 33256694 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific sensorimotor treatment (SMT)
Number of subjects: 34
Study 33256694 — intervention group
Group type: COMPARATOR
Intervention: General exercise (GE)
Number of subjects: 34
Study 33820711 — intervention group
Group type: EXPERIMENTAL
Intervention: Repetitive facilitative exercise (RFE) and botulinum toxin type A (BoNT‐A) injection
Number of subjects: 40
Study 33820711 — intervention group
Group type: COMPARATOR
Intervention: Repetitive facilitative exercise (RFE) only
Number of subjects: 40
Study 34678892 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Chong-Chet technique
Number of subjects: 129
Study 34678892 — intervention group
Group type: COMPARATOR
Intervention: Standard Chong-Chet technique
Number of subjects: 129
Study 32883231 — intervention group
Group type: EXPERIMENTAL
Intervention: EST‐SSR markers
Number of subjects: 0
Study 32883231 — intervention group
Group type: EXPERIMENTAL
Intervention: Population genetic analysis
Number of subjects: 0
Study 32883231 — intervention group
Group type: EXPERIMENTAL
Intervention: Migration rate analysis
Number of subjects: 0
Study 32883231 — intervention group
Group type: EXPERIMENTAL
Intervention: Bayesian structure analysis
Number of subjects: 0
Study 35089106 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise program
Number of subjects: 32
Study 35089106 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 32
Study 34603972 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-driven iCBT
Number of subjects: 55
Study 34603972 — intervention group
Group type: COMPARATOR
Intervention: Standard iCBT
Number of subjects: 55
Study 34603972 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 55
Study 35232469 — intervention group
Group type: EXPERIMENTAL
Intervention: Home visiting, iron supplementation, Participatory Learning and Action (PLA) groups, plus routine antenatal care (ANC)
Number of subjects: 842
Study 35232469 — intervention group
Group type: COMPARATOR
Intervention: Routine antenatal care (ANC)
Number of subjects: 842
Study 35491401 — intervention group
Group type: EXPERIMENTAL
Intervention: Biomarker-guided therapy
Number of subjects: 0
Study 35491401 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care therapy
Number of subjects: 0
Study 33925171 — intervention group
Group type: EXPERIMENTAL
Intervention: SEMS positioning (Group 1, 13 patients)
Number of subjects: 27
Study 33925171 — intervention group
Group type: COMPARATOR
Intervention: Open stomach-partitioning gastrojejunostomy (Group 2, 14 patients)
Number of subjects: 27
Study 35473432 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness induction
Number of subjects: 164
Study 35473432 — intervention group
Group type: COMPARATOR
Intervention: Active control task
Number of subjects: 164